Hospitals are selling longevity now. Some of their own doctors have doubts
At least nine nonprofit health systems now run cash-pay longevity clinics, with packages from $4,800 a year. Some of their own physicians question what patients are buying.
Latest
¡Hola, mundo!
Te damos la bienvenida a WordPress. Esta es tu primera entrada. Edítala o bórrala, ¡luego empieza a escribir!
FDA advisers split on a twice-yearly cholesterol shot, citing thin data in older patients
An FDA advisory panel voted 7-6 that the benefits of Corvane’s veltisiran outweigh its risks. Several members said the trial left out the patients most likely to use it.
Merriden will buy Halvard Bio for $2.1 billion after its kidney drug clears a key trial
The deal comes eight weeks after Halvard’s lead drug slowed kidney decline in a mid-stage trial. It is the year’s third biotech buyout over $2 billion.
Drug company meals for doctors track with more prescriptions of a pricey inhaler, analysis finds
Doctors who got at least four free meals from the maker of a $480 inhaler prescribed it about twice as often as doctors who got none, a Bedside analysis found.
The Chart: a measles count, a hospital merger, and why nurses are leaving nights
Good morning, it’s Hannah. Measles cases climb in eastern Oregon, two Ohio hospital systems agree to merge, and night-shift nurses say why they quit.
Opinion: I’ve worked 300 ER night shifts. Boarding is what breaks us
The hardest part of my job isn’t trauma. It’s the admitted patient who spends two days on a hallway stretcher because there is no bed upstairs.
A gut microbe may help explain why some patients sail through a common chemo side effect
In a study of 340 patients, those whose guts carried more of one bacterium had far less severe diarrhea during chemotherapy. The authors call it a lead, not a treatment.
Senate bill would cap what hospitals can charge for outpatient infusions
A bipartisan Senate bill would limit what hospital outpatient departments can charge for infusion drugs to what a doctor’s office is paid. Hospitals say it would close clinics.
Comings and goings: Corvane’s medical chief steps down, a new drug center head at the FDA, and more
Our weekly round-up of who is moving where in biotech, pharma and health policy. This week: four executives, one agency post and a dean.